Investigational anti-inflammatory agents for the treatment of ischaemic brain injury.

  • Xinkang Wang
  • Published 2005 in Expert opinion on investigational drugs

Abstract

Stroke is the third leading cause of death and the leading cause of disability in Western countries. To date, only approximately 2% of stroke patients are eligible for thrombolysis treatment with recombinant tissue plasminogen activator. The very limited options available for stroke treatment and recent disappointing clinical trials in stroke call for novel… (More)

Topics

Statistics

01020201520162017
Citations per Year

Citation Velocity: 8

Averaging 8 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Wang2005InvestigationalAA, title={Investigational anti-inflammatory agents for the treatment of ischaemic brain injury.}, author={Xinkang Wang}, journal={Expert opinion on investigational drugs}, year={2005}, volume={14 4}, pages={393-409} }